Product Program year 2025 Source: CMS Open Payments

E303

Biological Medical Oncology

Open in the dashboard

General payments

$16,392

15 payments

Research payments

$0

0 payments

Through program year 2025, $16,392 in general payments and $0 in research payments were reported against E303 (Medical Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $16,392 15

Breakdown

Who paid General payments · program year 2025
  1. Samsung Bioepis Co., Ltd. $16,392 15 payments
Top recipients General payments · program year 2025
  1. Vandana Abramson Medical Oncology · Nashville, TN $7,345 45% · 5 payments
  2. Pasi Antero Janne Medical Oncology · Boston, MA $5,265 32% · 4 payments
  3. Jonathan Rosenberg Medical Oncology · New York, NY $1,110 7% · 2 payments
  4. Joyce O'Shaughnessy Medical Oncology · Dallas, TX $1,061 6% · 2 payments
  5. Evan Yu Medical Oncology · Seattle, WA $1,040 6% · 1 payment

The top 5 of 6 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Medical Oncology Internal Medicine $16,392 100% · 6 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Tennessee $7,345 45% · 1 recipient
  2. Massachusetts $5,265 32% · 1 recipient
  3. New York $1,680 10% · 2 recipients
  4. Texas $1,061 6% · 1 recipient
  5. Washington $1,040 6% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

15 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record